Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Response of treatment-naive brain metastases to stereotactic radiosurgery

    With improvements in survival for patients with metastatic cancer, long-term local control of brain metastases has become an increasingly important clinical priority. While consensus guidelines recommend surge...

    Chibawanye I. Ene, Christina Abi Faraj, Thomas H. Beckham in Nature Communications (2024)

  2. Article

    Open Access

    The genomic alterations in glioblastoma influence the levels of CSF metabolites

    Cerebrospinal fluid (CSF) analysis is underutilized in patients with glioblastoma (GBM), partly due to a lack of studies demonstrating the clinical utility of CSF biomarkers. While some studies show the utilit...

    Daniel H. Wang, Yoko Fujita, Antonio Dono in Acta Neuropathologica Communications (2024)

  3. No Access

    Article

    Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer

    Genomic alterations are fundamental for molecular-guided therapy in patients with breast and lung cancer. However, the turn-around time of standard next-generation sequencing assays is a limiting factor in the...

    Srividya Arjuna, Mauli Shah, Antonio Dono, Luis Nunez-Rubiano in Journal of Neuro-Oncology (2024)

  4. No Access

    Article

    Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade

    Glioblastoma (GBM) tumors are enriched in immune-suppressive myeloid cells and are refractory to immune checkpoint therapy (ICT). Targeting epigenetic pathways to reprogram the functional phenotype of immune-s...

    Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh in Nature Cancer (2023)

  5. Article

    Open Access

    Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Immune-mediated anti-tumoral responses, elicited by oncolytic viruses and augmented with checkpoint inhibition, may be an effective treatment approach for glioblastoma. Here in this multicenter phase 1/2 study...

    Farshad Nassiri, Vikas Patil, Leeor S. Yefet, Olivia Singh, Jeff Liu in Nature Medicine (2023)

  6. Article

    Open Access

    Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

    A major rate-limiting step in develo** more effective immunotherapies for GBM is our inadequate understanding of the cellular complexity and the molecular heterogeneity of immune infiltrates in gliomas. Here...

    Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, Jia-Shiun Leu in Nature Communications (2022)

  7. No Access

    Article

    Long term outcomes following surgery for pineal region tumors

    Pineal region tumors are surgically demanding tumors to resect. Long term neuro-oncologic outcomes following surgical excision of tumors from this region have been underreported. We sought to define the long t...

    Matthew J. Shepard, Ali S. Haider, Sujit S. Prabhu in Journal of Neuro-Oncology (2022)

  8. Article

    Open Access

    Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

    Carla Danussi, Promita Bose, Prasanna T. Parthasarathy in Nature Communications (2022)

  9. No Access

    Article

    Considerations for designing preclinical cancer immune nanomedicine studies

    Immunotherapy is known to be clinically beneficial for cancer patients and in many cases represents the new standard of care. Because of this success, the interest in integrating nanomedicine with cancer immun...

    Wen Jiang, Yifan Wang, Jennifer A. Wargo, Frederick F. Lang in Nature Nanotechnology (2021)

  10. No Access

    Article

    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment

    Glioblastoma (GBM), or grade IV astrocytoma, is a malignant brain cancer that contains subpopulations of proliferative and invasive cells that coordinately drive primary tumor growth, progression, and recurren...

    John M. Lattier, Arpan De, Zhihua Chen, John E. Morales, Frederick F. Lang in Oncogene (2020)

  11. Article

    Open Access

    The role of resting-state functional MRI for clinical preoperative language map**

    Task-based functional MRI (tb-fMRI) is a well-established technique used to identify eloquent cortex, but has limitations, particularly in cognitively impaired patients who cannot perform language paradigms. R...

    Vinodh A. Kumar, Islam M. Heiba, Sujit S. Prabhu, Melissa M. Chen in Cancer Imaging (2020)

  12. Article

    Open Access

    A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities

    Personalized cancer treatments using combinations of drugs with a synergistic effect is attractive but proves to be highly challenging. Here we present an approach to uncover the efficacy of drug combinations ...

    Ravi S. Narayan, Piet Molenaar, Jian Teng, Fleur M. G. Cornelissen in Nature Communications (2020)

  13. Article

    Open Access

    Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a

    Disruption of the blood-brain barrier (BBB) by cancer cells is linked to metastatic tumor initiation and progression; however, the pathways that drive these events remain poorly understood. Here, we have devel...

    Shweta Tiwary, John E. Morales, Sam C. Kwiatkowski, Frederick F. Lang in Scientific Reports (2018)

  14. Article

    Open Access

    Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

    Mutational inactivation of the SWI/SNF chromatin regulator ATRX occurs frequently in gliomas, the most common primary brain tumors. Whether and how ATRX deficiency promotes oncogenesis by epigenomic dysregulation...

    Carla Danussi, Promita Bose, Prasanna T. Parthasarathy in Nature Communications (2018)

  15. Article

    Open Access

    Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells

    The majority of glioblastomas have aberrant receptor tyrosine kinase (RTK)/RAS/phosphoinositide 3 kinase (PI3K) signaling pathways and malignant glioma cells are thought to be addicted to these signaling pathw...

    Takashi Shingu, Lindsay Holmes, Verlene Henry in Journal of Translational Medicine (2016)

  16. No Access

    Article

    Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma

    Ten to twenty percent of newly diagnosed glioblastoma (GBM) patients initially present with multiple lesions, termed multifocal or multicentric GBM (M-GBM). The prognosis of these patients is poorer than that ...

    Qun Liu, Yuexin Liu, Wenliang Li, **aoguang Wang, Raymond Sawaya in Acta Neuropathologica (2015)

  17. No Access

    Article

    A history of the AANS/CNS Section on Tumors Biennial Satellite Symposium

    The Biennial Satellite Tumor Symposium is the flagship meeting of the AANS/CNS Section on Tumors. The year 2013 marked the 10th Tumor Section Biennial Satellite Tumor Symposium, a significant milestone warrant...

    Frederick F. Lang, Fred G. Barker II in Journal of Neuro-Oncology (2014)

  18. No Access

    Article

    Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens

    It was presented that mesenchymal stem cells (MSCs) can be isolated from western glioma specimens. However, whether MSCs exist in glioma specimens of different ethnicities is unknown. To verify the existence o...

    Young Goo Kim, Soyoun Jeon, Ga-Yeong Sin, **-Kyoung Shim in Child's Nervous System (2013)

  19. No Access

    Article

    Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens

    The existence of cancer stem cells (CSCs) in glioblastoma has been proposed. However, the unknown knowledge that is yet to be revealed is the presence of glioma CSCs (gCSCs) in correlation to each WHO grades o...

    Byung Ho Kong, Na-Ri Park, **-Kyoung Shim, Bo-Kyung Kim in Child's Nervous System (2013)

  20. No Access

    Article

    Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation

    Currently, the interaction between the niche and glioma cancer stem cells (gCSCs) is gaining attention. However, there are few studies concerned with the effects of repeated exposure to a new microenvironment ...

    Ga-Yeong Shin, **-Kyoung Shim, Ji-Hyun Lee, Hye-** Shin in Child's Nervous System (2013)

previous disabled Page of 2